secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001411690-25-000073
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BNGO holds annual meeting, re-elects directors, approves share issuance, appoints Vuori to audit committee
--------------------------------------------------------------------------------

- Kristiina Vuori appointed to Audit Committee effective June 10, 2025.
- Holmlin and Barker elected as Class I directors with 377,358 and 382,707 votes for, respectively.
- Advisory vote on executive compensation approved with 375,470 for, 328,513 against, showing notable dissent.
- Ratification of BDO USA as auditor approved (1,304,265 for vs 99,528 against).
- Issuance of up to 661,374 shares upon exercise of purchase warrants approved (369,176 for, 311,661 against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000141169025000073/0001411690-25-000073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000141169025000073/bngo-20250610.htm
  HTML page:      https://secwatch.observer/filing/0001411690-25-000073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer